In conclusion, the inexpensive clinical drug ciprofloxacin, a fluoroquinolone-class antibiotic, may activate the cGAS-STING signaling pathway and enhance the anti-PD1 therapeutic effects in colorectal cancer. The gene discussed is PDCD1; the disease is colorectal cancer.